J 2019

Defects in memory B-cell and plasma cell subsets expressing different immunoglobulin-subclasses in patients with CVID and immunoglobulin subclass deficiencies

BLANCO, Elena; Martin PEREZ-ANDRES; Sonia ARRIBA-MENDEZ; Cristina SERRANO; Ignacio CRIADO et al.

Základní údaje

Originální název

Defects in memory B-cell and plasma cell subsets expressing different immunoglobulin-subclasses in patients with CVID and immunoglobulin subclass deficiencies

Autoři

BLANCO, Elena; Martin PEREZ-ANDRES; Sonia ARRIBA-MENDEZ; Cristina SERRANO; Ignacio CRIADO; Lucia DEL PINO-MOLINA; Susana SILVA; Ignacio MADRUGA; Marina BAKARDJIEVA; Catarina MARTINS; Ana SERRA-CAETANO; Alfonso ROMERO; Teresa CONTRERAS-SANFELICIANO; Carolien BONROY; Francisco SALA; Alejandro MARTIN; Jose Maria BASTIDA; Felix LORENTE; Carlos PRIETO; Ignacio DAVILA; Miguel MARCOS; Tomas KALINA; Marcela VLKOVÁ; Zita CHOVANCOVÁ; Ana Isabel CORDEIRO; Jan PHILIPPE; Filomeen HAERYNCK; Eduardo LOPEZ-GRANADOS; Ana E. SOUSA; Mirjam VAN DER BURG; Jacques J. M. VAN DONGEN a Alberto ORFAO

Vydání

Journal of allergy and clinical immunology, New York, Mosby-Elsevier, 2019, 0091-6749

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30102 Immunology

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 10.228

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/19:00112958

Organizační jednotka

Lékařská fakulta

EID Scopus

Klíčová slova anglicky

Immunodeficiency; primary antibody deficiency; selective IgA deficiency; common variable immunodeficiency; immunophenotyping; immunoglobulins; immunoglobulin subclasses; memory B cells; plasma cells; flow cytometry; diagnosis; classification

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 17. 2. 2020 10:35, Mgr. Tereza Miškechová

Anotace

V originále

Background: Predominantly antibody deficiencies (PADs) are the most prevalent primary immunodeficiencies, but their B-cell defects and underlying genetic alterations remain largely unknown. Objective: We investigated patients with PADs for the distribution of 41 blood B-cell and plasma cell (PC) subsets, including subsets defined by expression of distinct immunoglobulin heavy chain subclasses. Methods: Blood samples from 139 patients with PADs, 61 patients with common variable immunodeficiency (CVID), 68 patients with selective IgA deficiency (IgAdef), 10 patients with IgG subclass deficiency with IgA deficiency, and 223 age matched control subjects were studied by using flow cytometry with EuroFlow immunoglobulin isotype staining. Patients were classified according to their B-cell and PC immune profile, and the obtained patient clusters were correlated with clinical manifestations of PADs. Results: Decreased counts of blood PCs, memory B cells (MB Cs), or both expressing distinct IgA and IgG subclasses were identified in all patients with PADs. In patients with IgAdef, B-cell defects were mainly restricted to surface membrane (sm)IgA(+) PCs and MBCs, with 2 clear subgroups showing strongly decreased numbers of smIgA(+) PCs with mild versus severe smIgA(+) MBC defects and higher frequencies of nonrespiratory tract infections, autoimmunity, and affected family members. Patients with IgG subclass deficiency with IgA deficiency and those with CVID showed defects in both smIgA(+) and smIgG(+) MBCs and PCs. Reduced numbers of switched PCs were systematically found in patients with CVID (absent in 98%), with 6 different defective MBC (and clinical) profiles: (1) profound decrease in MBC numbers; (2) defective CD27(+) MBCs with almost normal IgG(3)(+) MBCs; (3) absence of switched MBCs; and (4) presence of both unswitched and switched MBCs without and; (5) with IgG(2)(+) MBCs; and (6) with IgA(1)(+) MBCs. Conclusion: Distinct PAD defective B-cell patterns were identified that are associated with unique clinical profiles.